<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02374567</url>
  </required_header>
  <id_info>
    <org_study_id>GAP-2014</org_study_id>
    <nct_id>NCT02374567</nct_id>
  </id_info>
  <brief_title>Pharmacovigilance in Gerontopsychiatric Patients</brief_title>
  <acronym>GAP</acronym>
  <official_title>Pharmacovigilance in Gerontopsychiatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicenter-study is to investigate safety of psychopharmacological
      treatment and rates of adverse drug reactions in gerontopsychiatric inpatients. Elderly
      people are at higher risk for developing side effects under pharmacological treatment due to
      an altered metabolic situation, higher comorbidity rates and often polypharmacy. Furthermore
      gerontopsychiatric patients can often not articulate their symptoms clearly, for example due
      to pronounced cognitive impairment.

      The aim of the study is to gain valid data of possible adverse drug reaction rates, their
      potential risk factors and outcome, as well as medical prescription practises.

      To assess these outcomes an intensive pharmacovigilance-monitoring will be conducted at the
      five participating study sites.

      At Baseline demographic data, previous and present disorders, use of drugs, previous and
      present medication, quality of life, cognitive function, physical examination results,
      laboratory results and ECG will be assessed.

      Afterwards patients are visited weekly and screened for possible adverse drug reactions. All
      adverse drug reactions will be coded in the MedDRA-system.

      In case of a possible serious adverse drug reaction serum levels of all psychotropic
      substances applicated will be assessed. Drug combinations will be analysed using an
      established advanced bioinformatic tool (mediQ). Diagnosis, medication intake and possible
      adverse drug reactions are documented continually.

      2 weeks after discharge from the ward, patients will be contacted by phone to assess
      catamnestic data.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">June 28, 2017</completion_date>
  <primary_completion_date type="Actual">June 28, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of frequency and severity of adverse events</measure>
    <time_frame>Participants will be followed for the duration of hospital stay and the follow-up-visit, an expected average of 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of cognitive functioning</measure>
    <time_frame>At baseline visit and at the final visit (expected average of hospital stay: 4 weeks)</time_frame>
    <description>Mini mental state examination, intensive care delirium checklist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At baseline visit and at the final visit (expected average of hospital stay: 4 weeks)</time_frame>
    <description>SF-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse drug reactions</measure>
    <time_frame>Continuously during hospital stay (expected average of hospital stay: 4 weeks) and at follow-up two weeks after discharge</time_frame>
    <description>Dosage record and treatment emergent symptoms scale (DOTES), geriatric adverse event rating scale (GEARS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of substances</measure>
    <time_frame>1 day at occurrence of SAR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrocardiogram</measure>
    <time_frame>At baseline visit, at occurrence of SAR and at the final visit (expected average of hospital stay: 4 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication intake</measure>
    <time_frame>Patients medication intake 2 weeks before hospitalization, continuously during hospital stay (expected average of hospital stay: 4 weeks) and at follow-up two weeks after discharge</time_frame>
    <description>Morisky medication adherence scale (MMAS) and chart review</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">407</enrollment>
  <condition>Dementia</condition>
  <condition>Depression</condition>
  <condition>Schizophrenia</condition>
  <condition>Psychosomatic Disorders</condition>
  <condition>Anxiety Disorders</condition>
  <arm_group>
    <arm_group_label>Psychiatric drugs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenobarbital</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenytoin</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carbamazepine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxcarbazepine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valproic Acid</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lamotrigine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topiramate</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levetiracetam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lacosamide</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Biperiden</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levomepromazine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluphenazine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perphenazine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perazine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thioridazine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Haloperidol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melperone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pipamperone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bromperidol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benperidol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sertindole</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ziprasidone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flupentixol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorprothixene</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zuclopenthixol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluspirilene</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pimozide</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clozapine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Olanzapine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Quetiapine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sulpiride</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tiapride</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amisulpride</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prothipendyl</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risperidone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aripiprazole</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paliperidone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bromazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clobazam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alprazolam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyzine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buspirone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chloral Hydrate</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flurazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitrazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triazolam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lormetazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Temazepam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brotizolam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zopiclone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zolpidem</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zaleplon</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomethiazole</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diphenhydramine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Promethazine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Imipramine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomipramine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opipramol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trimipramine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amitriptyline</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nortriptyline</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxepin</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Maprotiline</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amitriptyline oxide</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoxetine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citalopram</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paroxetine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sertraline</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluvoxamine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Escitalopram</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranylcypromine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Moclobemide</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mianserin</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trazodone</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mirtazapine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupropion</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Venlafaxine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Reboxetine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Agomelatine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pyritinol</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piracetam</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Donepezil</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivastigmine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Galantamine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Memantine</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicergoline</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acamprosate</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lithium</intervention_name>
    <arm_group_label>Psychiatric drugs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 65+ years old

          -  Inpatients treated at one of the geriatric psychiatry study sites.

          -  Signed consent form ( Patient and/or legally authorized custodian)

        Exclusion Criteria:

          -  Patients that are incapable to give their informed consent and are not under legally
             authorized custodianship.

          -  Parallel participation in another clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helge Frieling, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bezirkskrankenhaus Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Hedwigshöhe</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Fachklinikum Lübben</name>
      <address>
        <city>Lübben</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Fachklinikum Teupitz</name>
      <address>
        <city>Teupitz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2015</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>geriatric psychiatry</keyword>
  <keyword>pharmacovigilance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Psychophysiologic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Diazepam</mesh_term>
    <mesh_term>Triazolam</mesh_term>
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Zolpidem</mesh_term>
    <mesh_term>Lorazepam</mesh_term>
    <mesh_term>Alprazolam</mesh_term>
    <mesh_term>Zopiclone</mesh_term>
    <mesh_term>Phenobarbital</mesh_term>
    <mesh_term>S 20098</mesh_term>
    <mesh_term>Chloral Hydrate</mesh_term>
    <mesh_term>Zaleplon</mesh_term>
    <mesh_term>Oxazepam</mesh_term>
    <mesh_term>Temazepam</mesh_term>
    <mesh_term>Brotizolam</mesh_term>
    <mesh_term>Lormetazepam</mesh_term>
    <mesh_term>Nitrazepam</mesh_term>
    <mesh_term>Flurazepam</mesh_term>
    <mesh_term>Chlormethiazole</mesh_term>
    <mesh_term>Clomethiazole edisylate</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Buspirone</mesh_term>
    <mesh_term>Trazodone</mesh_term>
    <mesh_term>Fluvoxamine</mesh_term>
    <mesh_term>Tranylcypromine</mesh_term>
    <mesh_term>Bromazepam</mesh_term>
    <mesh_term>Clonazepam</mesh_term>
    <mesh_term>Risperidone</mesh_term>
    <mesh_term>Melatonin</mesh_term>
    <mesh_term>Aripiprazole</mesh_term>
    <mesh_term>Olanzapine</mesh_term>
    <mesh_term>Quetiapine Fumarate</mesh_term>
    <mesh_term>Paliperidone Palmitate</mesh_term>
    <mesh_term>Valproic Acid</mesh_term>
    <mesh_term>Haloperidol</mesh_term>
    <mesh_term>Ziprasidone</mesh_term>
    <mesh_term>Clozapine</mesh_term>
    <mesh_term>Amitriptyline, perphenazine drug combination</mesh_term>
    <mesh_term>Carbamazepine</mesh_term>
    <mesh_term>Sultopride</mesh_term>
    <mesh_term>Sertindole</mesh_term>
    <mesh_term>Flupenthixol</mesh_term>
    <mesh_term>Flupenthixol decanoate</mesh_term>
    <mesh_term>Perphenazine</mesh_term>
    <mesh_term>Fluphenazine</mesh_term>
    <mesh_term>Fluphenazine depot</mesh_term>
    <mesh_term>Fluphenazine enanthate</mesh_term>
    <mesh_term>Pimozide</mesh_term>
    <mesh_term>Sulpiride</mesh_term>
    <mesh_term>Thioridazine</mesh_term>
    <mesh_term>Pipamperone</mesh_term>
    <mesh_term>Chlorprothixene</mesh_term>
    <mesh_term>Methotrimeprazine</mesh_term>
    <mesh_term>Clopenthixol</mesh_term>
    <mesh_term>Fluspirilene</mesh_term>
    <mesh_term>Benperidol</mesh_term>
    <mesh_term>Perazine</mesh_term>
    <mesh_term>Bromperidol</mesh_term>
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Bupropion</mesh_term>
    <mesh_term>Donepezil</mesh_term>
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
    <mesh_term>Sertraline</mesh_term>
    <mesh_term>Memantine</mesh_term>
    <mesh_term>Fluoxetine</mesh_term>
    <mesh_term>Paroxetine</mesh_term>
    <mesh_term>Lamotrigine</mesh_term>
    <mesh_term>Venlafaxine Hydrochloride</mesh_term>
    <mesh_term>Promethazine</mesh_term>
    <mesh_term>Galantamine</mesh_term>
    <mesh_term>Rivastigmine</mesh_term>
    <mesh_term>Mirtazapine</mesh_term>
    <mesh_term>Amitriptyline</mesh_term>
    <mesh_term>Nortriptyline</mesh_term>
    <mesh_term>Reboxetine</mesh_term>
    <mesh_term>Imipramine</mesh_term>
    <mesh_term>Hydroxyzine</mesh_term>
    <mesh_term>Clomipramine</mesh_term>
    <mesh_term>Doxepin</mesh_term>
    <mesh_term>Biperiden</mesh_term>
    <mesh_term>Mianserin</mesh_term>
    <mesh_term>Trimipramine</mesh_term>
    <mesh_term>Opipramol</mesh_term>
    <mesh_term>Maprotiline</mesh_term>
    <mesh_term>Nicergoline</mesh_term>
    <mesh_term>Moclobemide</mesh_term>
    <mesh_term>Topiramate</mesh_term>
    <mesh_term>Etiracetam</mesh_term>
    <mesh_term>Lacosamide</mesh_term>
    <mesh_term>Oxcarbazepine</mesh_term>
    <mesh_term>Clobazam</mesh_term>
    <mesh_term>Phenytoin</mesh_term>
    <mesh_term>Acamprosate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

